Business

Organ-on-a-chip Company (OOC) CN Bio has appointed a new Chief Business Officer as part of its commercial business strategy. The company has appointed Dr Paul Brooks to the role, who will be responsible for leading the expansion of its global commercial organisation. Dr Brooks has over 25 years of experience in the life science industry, […]

Software company Insightful Science has announced it is retiring its brand name and will go forward under the name Dotmatics.  The rebrand follows the merger of Insightful Science and Dotmatic in 2021 and the organisation now has a global team of over 800 employees, supporting customers in more than 180 countries.   Dotmatics has recently added […]

DDW Deputy Editor Reece Armstrong looks at the key points of GSK’s first quarter earnings.   UK pharmaceutical company GSK has reported strong financial earnings for the first quarter of 2022.  The pharma giant reported total sales in Q1 of £9.8 billion, crediting much of that to the company’s biopharma offerings.  In a breakdown of GSK’s […]

Kizoo Technology Capital has a clear aim – to develop drugs that abate or cure age-related diseases. Lu Rahman spoke to owner, Michael Greve to find out more about this exciting work that aims to make age-related therapies affordable for everyone. Kizoo is investing €300 million in a portfolio of private science-backed biotechnology companies which […]

Drug development consultancy Boyds has bolstered its clinical trials expertise with the appointment of Caroline Corbett as Director of Clinical Operations.   As Director of Clinical Operations at Boyds, Corbett will support Dr Karen O’Hanlon, Vice President of Clinical Operations, with the ongoing growth and development of the clinical operations team and service offering. Corbett […]

BioXcel Therapeutics has raised $260 million in funding to support the commercial activities of its proprietary, orally dissolving film formulation IGALMI. Previously known as BXCL501, IGALMI is an orally dissolving film formulation of dexmedetomidine indicated for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The funding comes […]

GlaxoSmithKline (GSK) is to acquire biopharmaceutical company Sierra Oncology in a deal worth £1.5 billion, the company has announced.   Sierra Oncology  Sierra Oncology is a late-stage company focused on targeted therapies for the treatment of rare forms of cancer. The company’s lead asset, momelotinib, is being investigated as a treatment for myelofibrosis – a fatal […]

Biotechnology company CellCentric has strengthened its leadership team with two new appointments. The company has appointed Kris Frese as Director of Cancer Biology, and Andrew Hughes, who joins the Board as a Non-Executive Director.   Kris Frese is an experienced cancer biologist who specialises in models of cancer and biomarker analysis. Frese most recently served as […]

South Korea is supporting innovative pharmaceutical companies by revising the health insurance benefits system. The new system of preferential drug pricing, if designed effectively, can boost innovation in the country’s pharmaceutical research, says GlobalData.  According to GlobalData, the pharmaceutical market in South Korea is estimated to grow at a compound annual growth rate (CAGR) of 3.8% to […]

Andrew Aldridge, Partner at  Deepbridge Capital explains why life science sector has shot up the UK investment agenda as vaccinations are rolled out. The past twelve months have showcased the importance of medical developments like never before. Innovation in the life sciences sector has been headline news around the globe and all aspects of the healthcare system have been under the […]